Free Cash Flow for AbbVie (ABBV)
Free Cash Flow for AbbVie (ABBV): headline value $18.70B · YoY -0.1%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ABBV
Currently viewingFree Cash FlowSwitch metric
Latest period
$18.70B
YoY change
-0.1%
5Y CAGR
+1.2%
Peak year (2022)
$24.25B
Latest annual
$17.82B
Free Cash Flow history chart for AbbVie (ABBV) from 2009 to 2025
Free Cash Flow history table for AbbVie (ABBV) from 2009 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $17.82B | -0.1% | ||
| 2024 | $17.83B | -19.2% | ||
| 2023 | $22.06B | -9.0% | ||
| 2022 | $24.25B | +10.3% | ||
| 2021 | $21.99B | +31.0% | ||
| 2020 | $16.79B | +31.5% | ||
| 2019 | $12.77B | -0.1% | ||
| 2018 | $12.79B | +35.6% | ||
| 2017 | $9.43B | +43.7% | ||
| 2016 | $6.56B | -6.3% | ||
| 2015 | $7.00B | +138.4% | ||
| 2014 | $2.94B | -49.2% | ||
| 2013 | $5.78B | -3.9% | ||
| 2012 | $6.01B | +2.0% | ||
| 2011 | $5.89B | +30.1% | ||
| 2010 | $4.53B | -10.4% | ||
| 2009 | $5.05B | — |
Free Cash Flow values are taken from AbbVie's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of AbbVie (ABBV) free cash flow is $17.82B – edged down 0.1% year-over-year.
Over 2020–2025 (5 years), AbbVie free cash flow expanded at a +1.2% compound annual rate, with the latest reading among the more recent periods of the dataset.
AbbVie free cash flow peaked at $24.25B in 2022; the latest annual figure is $17.82B in 2025 (26.5% below peak).
The dataset's maximum free cash flow sits at $24.25B (2022); the minimum reading of $2.94B dates to 2014.
Within Healthcare, AbbVie (ABBV) ranks 3rd among 8 peers we track. The peer median for free cash flow is $12.06B.
AbbVie Free Cash Flow by Year
AbbVie Free Cash Flow 2025: $17.82B
AbbVie free cash flow in 2025 was $17.82B, edged down 0.1% below 2024.
AbbVie Free Cash Flow 2024: $17.83B
AbbVie free cash flow in 2024 was $17.83B, declined 19.2% below 2023.
AbbVie Free Cash Flow 2023: $22.06B
AbbVie free cash flow in 2023 was $22.06B, declined 9.0% below 2022.
AbbVie Free Cash Flow 2022: $24.25B
AbbVie free cash flow in 2022 was $24.25B, grew 10.3% from 2021. This figure represents the highest annual value in the available history.
AbbVie Free Cash Flow 2021: $21.99B
AbbVie free cash flow in 2021 was $21.99B.
See more financial history for AbbVie (ABBV).
Sector peers — Free Cash Flow
Companies in the same sector as AbbVie, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $6.29B | Healthcare |
Frequently asked questions
What is AbbVie's free cash flow?
Latest reported free cash flow for AbbVie (ABBV) is $18.70B (period ending December 31, 2025).
How has AbbVie free cash flow changed year-over-year?
AbbVie (ABBV) free cash flow changed -0.1% year-over-year on the latest annual filing.
What is the long-term growth rate of AbbVie free cash flow?
AbbVie (ABBV) free cash flow compound annual growth rate is +1.2% over the most recent 5 years available.
When did AbbVie free cash flow hit its highest annual value?
AbbVie free cash flow reached its highest annual value of $24.25B in 2022.
What was AbbVie free cash flow in 2024?
AbbVie (ABBV) free cash flow in 2024 was $17.83B.
What was AbbVie free cash flow in 2025?
AbbVie (ABBV) free cash flow in 2025 was $17.82B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ABBV Overview
Company profile, financial tools, and key metrics
ABBV Revenue Counter
Earns $1,939 every second. See per minute, hour, and day.
ABBV Earnings Counter
Earns $134.01 per second net profit. See per minute, hour, and day.
ABBV Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
ABBV What If Invested
What if you had invested $1,000? See historical returns from any date.
ABBV How It Makes Money
Discover visual breakdown of $61.16B in revenue — where it comes from and where it goes.
ABBV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABBV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABBV Daily Price Character
Steady · 53.5% historical win rate (green days). Streaks & record days.
ABBV Buybacks
0.24% TTM buyback yield. Shareholder yield & SBC comparison.
ABBV Dividend Profile
Yield: 3.31%. Safety: 6/8. See full history.
ABBV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABBV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.